Summary
Compiles health economics data, payer landscape analysis, and reimbursement precedents to support market access strategy and value dossier development.
Detailed Description
The Market Access Evidence Pack supports sponsors in developing evidence-based market access strategies and payer value propositions. It aggregates health economics data, payer coverage policies, reimbursement precedents, and health technology assessment (HTA) outcomes to inform pricing, market access planning, and value dossier development.
The pack analyzes the payer landscape for your therapeutic area, including commercial and government payer coverage policies, formulary placement patterns, and prior authorization requirements. It benchmarks pricing and access outcomes for analogous products and identifies the evidence requirements for favorable payer decisions.
Deliverables include a market access landscape assessment, a value dossier framework with evidence gap analysis, and a pricing and reimbursement benchmarking analysis across comparable therapies in your indication.
Evidence Sources
| Source | Type | Description | Refresh |
|---|---|---|---|
| Health Economics Database | LITERATURE | Published cost-effectiveness analyses, budget impact models, and health economics studies | Weekly |
| Payer Coverage Database | CURATED | Commercial and Medicare/Medicaid coverage policies, formulary data, and utilization management criteria | Monthly |
| HTA Decision Database | REGULATORY | Health technology assessment decisions from NICE, ICER, CADTH, and other HTA bodies | Monthly |
Regulatory Mapping
Guide to the Methods of Technology Appraisal
ICER Value Assessment Framework
ISPOR Good Practices for Outcomes Research
Agent Transparency
When you run this pack, your request is processed by a pipeline of specialized AI agents. Each agent operates with a defined confidence threshold and is auditable end-to-end.
Evidence Retriever
brew-retriever-v3
Queries curated sources for relevant evidence objects. Searches across regulatory databases, clinical registries, and scientific literature to surface the most pertinent references for the pack domain.
Domain Analyzer
brew-domain-analyst-v2
Applies domain-specific reasoning and regulatory mapping. Interprets evidence in the context of FDA, ICH, and EMA frameworks and tags each finding with the relevant guidance references.
Evidence Synthesizer
brew-synthesizer-v2
Synthesizes findings into structured output. Combines retrieved evidence and domain analysis into a cohesive narrative with quantitative summaries, comparative tables, and actionable recommendations.
Output Validator
brew-validator-v1
Validates citations, checks confidence thresholds, and ensures all referenced sources are accessible and correctly attributed. Flags any claims that fall below the confidence floor.
Sample Outputs
Market Access Landscape Assessment
PDFComprehensive assessment of the payer landscape including coverage policies and access barriers
Value Dossier Framework
DOCXAMCP-format value dossier framework with evidence gap analysis and data generation recommendations
Pricing & Reimbursement Benchmarking
XLSXComparative pricing and reimbursement analysis across analogous therapies in the target indication
Deliverables included
- Market access landscape assessment
- AMCP-format value dossier framework
- Pricing and reimbursement benchmarking analysis
- Evidence gap analysis for payer decision-making
- HTA submission strategy and timeline
Related Disease & Biomarker Mappings
| Therapeutic Area | Disease Family | Key Biomarkers | Relevance |
|---|---|---|---|
| Cross-Therapeutic | Pipeline Competitive Landscape | Market differentiation markers | Primary |
| Oncology | IO Competitive Landscape | PD-(L)1 AgentsLAG-3TIGIT | Secondary |
Related Packs in Competitive Intelligence
Version History
Current release — expanded evidence sources, improved citation accuracy, and added new regulatory cross-references.
Beta release — validated with domain SMEs. Added sample output previews and refined confidence scoring.
Initial draft — core evidence retrieval pipeline and output schema established.
Need a Custom Evidence Pack?
Our enterprise team can build bespoke evidence packs tailored to your therapeutic area, regulatory strategy, or internal decision framework. Custom packs include dedicated evidence source curation, domain-specific agent tuning, and priority SLA support.
Enterprise packs are available for organizations on the BrewBio Pro or Enterprise plan.